What is the main difference between tirzepatide and other similar medications like semaglutide
For example, if genetic testing reveals a predisposition toward heightened GLP-1 receptor sensitivity, a more conservative titration timeline or lower maintenance dose may prove optimal
Wegovy is a glucagon-like peptide-1 (GLP-1) receptor agonist for chronic weight management, along with a reduced calorie diet and increased physical activity, for people with an initial body mass index (BMI) of: 30 kg/m2 or greater (obesity) or 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, type 2 diabetes mellitus, or dyslipidemia)
This triple mechanism provides complementary metabolic effects: GLP-1R activation suppresses appetite and enhances glucose-dependent insulin secretion
At Lake Forest Regenesis in Lake Forest, IL, we provide medical weight loss with tirzepatide through individualized treatment plans and provider-supervised care